TACR1 and cancer: In addition, SP enhances the expression of factors involved in cellular migration (e.g., matrix metalloproteinases 2 and 9) and promotes plasma membrane blebbing, and hence, the peptide promotes the migration of cancer cells; however, NK-1R antagonists block such migration [53,131,132].